Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
64Cu-DOTA-ECL1i PET Imaging in Inflammatory Heart Disease
NCT05107596Phase 1Unknown
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2018
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, open-label trial of Cu-DOTA-ECL1i in myocardial infarction (MI), sarcoidosis, myocarditis and 2 more, sponsored by Washington University School of Medicine. Status: unknown.
02
Drugs
Cu-DOTA-ECL1i
03
Conditions
myocardial infarction (MI)sarcoidosismyocarditiscardiomyopathycardiovascular implantable electronic device infection (CIED-I)
Beyond the preview
Go deeper on NCT05107596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05107596.